Disc Medicine CLO exercises options, sells shares
Disc Medicine, Inc. Chief Legal Officer Rahul Khara exercised 5,000 stock options for common stock at an exercise price of $14.69 per share and acquired 5,000 shares, then sold 5,000 common shares at $80.00 per share on August 6, 2026.
Rhea-AI Filing Summary
Disc Medicine, Inc. Chief Legal Officer Rahul Khara exercised 5,000 stock options for common stock at an exercise price of $14.69 per share and acquired 5,000 shares, then sold 5,000 common shares at $80.00 per share on August 6, 2026. Following the exercise, 49,804 option shares tied to this award remained outstanding. All reported transactions were effected under a Rule 10b5-1 trading plan adopted on March 19, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 5,000 shares ($327K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Khara Rahul
Role
Chief Legal Officer
Sold
5,000 shs ($400K)
Approx. gross sale proceeds
$400K
Approx. exercise cost
$73K
Approx. pre-tax spread
$327K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F3 | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 5,000 | $14.69 | $73K |
| Sale | Common Stock F1, F2 | 5,000 | $80.00 | $400K |
Holdings After Transaction:
Stock Option (Right to Buy) — 49,804 contracts (Direct);
Common Stock — 52,324 shares (Direct)
Footnotes (3)
- F1. The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026.
- F2. Includes 151 shares purchased pursuant to the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026.
- F3. The shares underlying this option are fully vested and exercisable as of the date hereof.
Key Figures
Options exercised: 5,000 shares
Exercise price: $14.69 per share
Shares sold: 5,000 shares
+4 more
7 metrics
Options exercised
5,000 shares
Stock options for common stock exercised on August 6, 2026
Exercise price
$14.69 per share
Exercise or conversion price of the Stock Option (Right to Buy)
Shares sold
5,000 shares
Common stock sale on August 6, 2026
Sale price
$80.00 per share
Price per share for sale of Disc Medicine common stock
Options remaining
49,804 shares
Stock Option (Right to Buy) shares following reported option exercise
ESPP shares included
151 shares
Common shares purchased under the 2021 Employee Stock Purchase Plan on July 31, 2026
10b5-1 plan adoption date
March 19, 2026
Adoption date of Rule 10b5-1 trading plan governing these transactions
Key Terms
Rule 10b5-1 trading plan, Stock Option (Right to Buy), Employee Stock Purchase Plan, derivative security
4 terms
Rule 10b5-1 trading plan regulatory
"transactions reported were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
"security_title listed as Stock Option (Right to Buy)"
Employee Stock Purchase Plan financial
"purchased pursuant to the Amended and Restated 2021 Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Disc Medicine (IRON) Chief Legal Officer Rahul Khara report?
Rahul Khara reported exercising 5,000 stock options for Disc Medicine (IRON) common stock at $14.69 per share and selling 5,000 common shares at $80.00 per share on August 6, 2026, under a pre-arranged Rule 10b5-1 trading plan.
How many Disc Medicine (IRON) options did Rahul Khara exercise and at what price?
He exercised 5,000 stock options for Disc Medicine (IRON) common stock at an exercise price of $14.69 per share. These options were fully vested and exercisable as of the transaction date, according to the filing’s option-related footnote.
Were Rahul Khara’s Disc Medicine (IRON) transactions made under a Rule 10b5-1 plan?
Yes. All reported transactions were effected under a Rule 10b5-1 trading plan adopted on March 19, 2026. The plan status is confirmed both by a filing-level checkbox and by a specific trading-plan footnote tied to the transactions.
How many stock options remain after Rahul Khara’s August 6, 2026 Disc Medicine (IRON) transactions?
After exercising 5,000 options, the filing reports 49,804 option shares remaining for the referenced Stock Option (Right to Buy). This figure reflects the total shares underlying that derivative security following the August 6, 2026 exercise.
What does the Employee Stock Purchase Plan footnote mean for Disc Medicine (IRON) holdings?
A footnote states that Khara’s reported common share holdings include 151 shares purchased under the Disc Medicine, Inc. Amended and Restated 2021 Employee Stock Purchase Plan on July 31, 2026, clarifying that these ESPP shares are part of his direct ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
